Flywire Corp |
Other* |
Common Stock |
7.27M |
$135M |
$18.58 |
May 28, 2021 |
F-Prime Capital Partners Tech Fund LP |
Toast, Inc. |
Other* |
Class B Common Stock |
6.7M |
$113M |
$16.92 |
Nov 9, 2021 |
F-Prime Capital Partners Tech Fund LP |
Beam Therapeutics Inc. |
Other* |
Common Stock |
2.77M |
$85.7M |
$30.93 |
Feb 13, 2024 |
Shares held by persons and entities whose shares are subject to reporting by the undersigned |
Neumora Therapeutics, Inc. |
Other* |
Common Stock |
5.47M |
$65.6M |
$11.98 |
Sep 19, 2023 |
F-Prime Capital Partners Life Sciences Fund VII LP |
Prime Medicine, Inc. |
Other* |
Common Stock |
4.23M |
$63.3M |
$14.97 |
Oct 24, 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
Prime Medicine, Inc. |
Other* |
Common Stock |
4.12M |
$61.7M |
$14.97 |
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Structure Therapeutics Inc. |
Other*, 10%+ Owner |
American Depositary Shares |
1.54M |
$54M |
$35.00 |
Apr 17, 2024 |
Shares held by persons and entities whose shares are subject to reporting by the undersigned |
Sana Biotechnology, Inc. |
Other*, 10%+ Owner |
Common Stock |
4.83M |
$45.7M |
$9.45 |
Apr 1, 2024 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Beam Therapeutics Inc. |
Other* |
Common Stock |
1.24M |
$38.7M |
$31.34 |
Feb 14, 2024 |
F-Prime Capital Partners Healthcare Fund V LP |
Rallybio Corp |
Other* |
Common Stock |
1.69M |
$13.9M |
$8.20 |
Aug 2, 2021 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Verve Therapeutics, Inc. |
Other* |
Common Stock |
571K |
$5.71M |
$10.00 |
Jul 26, 2022 |
F-Prime Capital Partners Healthcare Fund V LP |
Caribou Biosciences, Inc. |
Other* |
Common Stock |
1.84M |
$5.45M |
$2.96 |
Jul 27, 2021 |
F-Prime Capital Partners Healthcare Fund IV LP |
Caribou Biosciences, Inc. |
Other* |
Common Stock |
1.46M |
$4.34M |
$2.96 |
Jul 27, 2021 |
Impresa Fund III Limited Partnership |
Prime Medicine, Inc. |
Other* |
Common Stock |
110K |
$1.65M |
$14.97 |
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Xilio Therapeutics, Inc. |
Other* |
Common Stock |
1.53M |
$1.27M |
$0.83 |
Oct 26, 2021 |
F-Prime Capital Partners Healthcare Fund IV LP |
Structure Therapeutics Inc. |
Other*, 10%+ Owner |
American Depositary Shares |
32.2K |
$1.13M |
$35.00 |
Apr 17, 2024 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Neumora Therapeutics, Inc. |
Other* |
Common Stock |
88.3K |
$1.06M |
$11.98 |
Sep 19, 2023 |
FBRI LLC |
Neumora Therapeutics, Inc. |
Other* |
Common Stock |
63.7K |
$763K |
$11.98 |
Sep 19, 2023 |
F-Prime Inc. |
Xilio Therapeutics, Inc. |
Other* |
Common Stock |
372K |
$309K |
$0.83 |
Oct 26, 2021 |
Impresa Fund III Limited Partnership |
Structure Therapeutics Inc. |
Other*, 10%+ Owner |
American Depositary Shares |
2.73K |
$95.7K |
$35.00 |
Apr 17, 2024 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Caribou Biosciences, Inc. |
Other* |
Common Stock |
17.6K |
$52K |
$2.96 |
Jul 27, 2021 |
F-Prime Capital Partners Healthcare Advisors Fund IV LP |
Fidelity Private Credit Fund |
Other* |
Class D Common Shares of Beneficial Interest |
398 |
$10.2K |
$25.54 |
Jan 29, 2024 |
FMR Capital Inc. |
Fidelity Private Credit Fund |
Other* |
Class S Common Shares of Beneficial Interest |
398 |
$10.2K |
$25.54 |
Jan 29, 2024 |
FMR Capital Inc. |
Xilio Therapeutics, Inc. |
Other* |
Common Stock |
4.47K |
$3.71K |
$0.83 |
Oct 26, 2021 |
F-Prime Capital Partners Healthcare Advisors Fund IV LP |
Structure Therapeutics Inc. |
Other*, 10%+ Owner |
American Depositary Shares |
41 |
$1.44K |
$35.00 |
Apr 17, 2024 |
FIMM, LLC |
Fidelity Multi-Strategy Credit Fund |
Other*, 10%+ Owner |
Common Shares of Beneficial Ownership |
2.5M |
|
|
May 19, 2023 |
Direct |
Fidelity Private Credit Fund |
Other* |
Class I Common Shares of Beneficial Interest |
1.28M |
|
|
Jan 29, 2024 |
Direct |
Bicara Therapeutics Inc. |
Other* |
Common Stock |
1.12M |
|
|
Sep 16, 2024 |
F-Prime Capital Partners Life Sciences Fund VII LP |
Turnstone Biologics Corp. |
Other* |
Common Stock |
833K |
|
|
Jan 9, 2024 |
F-Prime Capital Partners Healthcare Fund V LP |
Structure Therapeutics Inc. |
Other*, 10%+ Owner |
Ordinary Shares |
531K |
|
|
Jun 6, 2024 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Fidelity Private Credit Fund |
Other* |
Class I Common Shares of Beneficial Interest |
352K |
|
|
Jan 29, 2024 |
Fidelity Multi-Strategy Credit Fund |
Turnstone Biologics Corp. |
Other* |
Common Stock |
296K |
|
|
Jan 9, 2024 |
Impresa Fund III Limited Partnership |
Structure Therapeutics Inc. |
Other*, 10%+ Owner |
Ordinary Shares |
45.1K |
|
|
Jun 6, 2024 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Turnstone Biologics Corp. |
Other* |
Common Stock |
4.94K |
|
|
Jan 9, 2024 |
F-Prime Capital Partners Healthcare Advisors Fund V LP |
Fidelity Private Credit Fund |
Other* |
Class I Common Shares of Beneficial Interest |
86.1 |
|
|
Jan 29, 2024 |
FMR Capital Inc. |
Bicara Therapeutics Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
Sep 16, 2024 |
F-Prime Capital Partners Life Sciences Fund VII LP |
Bicara Therapeutics Inc. |
Other* |
Series C Preferred Stock |
0 |
|
|
Sep 16, 2024 |
F-Prime Capital Partners Life Sciences Fund VII LP |
Bicara Therapeutics Inc. |
Other* |
Series Seed Preferred Stock |
0 |
|
|
Sep 16, 2024 |
F-Prime Capital Partners Life Sciences Fund VII LP |
Caribou Biosciences, Inc. |
Other* |
Series A-1 Preferred Stock |
0 |
|
|
Jul 27, 2021 |
F-Prime Capital Partners Healthcare Advisors Fund IV LP |
Caribou Biosciences, Inc. |
Other* |
Series A-1 Preferred Stock |
0 |
|
|
Jul 27, 2021 |
F-Prime Capital Partners Healthcare Fund IV LP |
Caribou Biosciences, Inc. |
Other* |
Series A-1 Preferred Stock |
0 |
|
|
Jul 27, 2021 |
Impresa Fund III Limited Partnership |
Caribou Biosciences, Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
Jul 27, 2021 |
F-Prime Capital Partners Healthcare Fund IV LP |
Flywire Corp |
Other* |
Series A Preferred Stock |
0 |
|
|
May 28, 2021 |
F-Prime Capital Partners Tech Fund LP |
Flywire Corp |
Other* |
Series B-1 NV Preferred Stock |
0 |
|
|
May 28, 2021 |
F-Prime Capital Partners Tech Fund LP |
Flywire Corp |
Other* |
Series B-1 Preferred Stock |
0 |
|
|
May 28, 2021 |
F-Prime Capital Partners Tech Fund LP |
Flywire Corp |
Other* |
Series B Preferred Stock |
0 |
|
|
May 28, 2021 |
F-Prime Capital Partners Tech Fund LP |
Flywire Corp |
Other* |
Series C Preferred Stock |
0 |
|
|
May 28, 2021 |
F-Prime Capital Partners Tech Fund LP |
Neumora Therapeutics, Inc. |
Other* |
Series A-2 Preferred Stock |
0 |
|
|
Sep 19, 2023 |
FBRI LLC |
Neumora Therapeutics, Inc. |
Other* |
Series A-2 Preferred Stock |
0 |
|
|
Sep 19, 2023 |
F-Prime Capital Partners Life Sciences Fund VII LP |
Neumora Therapeutics, Inc. |
Other* |
Series A-2 Preferred Stock |
0 |
|
|
Sep 19, 2023 |
F-Prime Inc. |
Neumora Therapeutics, Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
Sep 19, 2023 |
F-Prime Capital Partners Life Sciences Fund VII LP |
Prime Medicine, Inc. |
Other* |
Series A Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
Prime Medicine, Inc. |
Other* |
Series A Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Prime Medicine, Inc. |
Other* |
Series A Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Prime Medicine, Inc. |
Other* |
Series B Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
Prime Medicine, Inc. |
Other* |
Series B Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Rallybio Corp |
Other* |
Series B Preferred Units |
0 |
|
|
Aug 2, 2021 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Turnstone Biologics Corp. |
Other* |
Series B-1 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
F-Prime Capital Partners Healthcare Fund V LP |
Turnstone Biologics Corp. |
Other* |
Series B-2 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
F-Prime Capital Partners Healthcare Advisors Fund V LP |
Turnstone Biologics Corp. |
Other* |
Series B-2 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
F-Prime Capital Partners Healthcare Fund V LP |
Turnstone Biologics Corp. |
Other* |
Series B-2 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
Impresa Fund III Limited Partnership |
Turnstone Biologics Corp. |
Other* |
Series C Preferred Stock |
0 |
|
|
Jul 25, 2023 |
F-Prime Capital Partners Healthcare Fund V LP |
Turnstone Biologics Corp. |
Other* |
Series D Preferred Stock |
0 |
|
|
Jul 25, 2023 |
F-Prime Capital Partners Healthcare Fund V LP |
Xilio Therapeutics, Inc. |
Other* |
Series A-1 Preferred Stock |
0 |
|
|
Oct 26, 2021 |
F-Prime Capital Partners Healthcare Fund IV LP |
Xilio Therapeutics, Inc. |
Other* |
Series A Preferred Stock |
0 |
|
|
Oct 26, 2021 |
F-Prime Capital Partners Healthcare Fund IV LP |
Xilio Therapeutics, Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
Oct 26, 2021 |
F-Prime Capital Partners Healthcare Advisors Fund IV LP |
Xilio Therapeutics, Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
Oct 26, 2021 |
F-Prime Capital Partners Healthcare Fund IV LP |
Xilio Therapeutics, Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
Oct 26, 2021 |
Impresa Fund III Limited Partnership |